Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11485770
Anti-VEGF protein compositions and methods for producing the same
granted -
US 11485793
Anti-MUC16 antibodies, antibody-drug conjugates, and bispecific antigen-binding molecules that bind MUC16 and CD3, and uses thereof
granted -
US 11485961
Compositions and methods for treating celiac sprue disease
granted -
US 11486802
Methods and devices for high throughput purification
granted -
US 11484602
Bicyclic peptide ligands specific for EphA2
granted -
US 11484477
Dental adhesive material kit
granted -
US 11484603
Methods, systems, and compositions for inhibiting virulence of A/E family pathogens
granted -
US 11485734
Beta-carbolines as positive allosteric modulators of the human serotonin receptor 2C (5-HT2C)
granted -
US 11484581
Method to create personalized canine cancer vaccines
granted -
US 11484591
Chemoprevention using controlled-release formulations of anti-interleukin 6 agents, synthetic vitamin A analogues or metabolites, and estradiol metabolites
granted -
US 11485732
Compounds and uses thereof
granted -
US 11485709
Cannabinoid receptor mediating compounds
granted -
US 11485958
HSD17B13 variants and uses thereof
granted -
US 11484523
Compositions for prevention and treatment of symptoms associated with alcohol consumption
granted -
US 11484521
Antidotes to cyanide poisoning
granted -
US 11484511
Pharmaceutical composition comprising THA as effective ingredient for treatment of prostate cancer
granted -
US 11485739
Compounds useful as inhibitors of ATR kinase
granted -
US 11484573
Activin receptor type IIa variants and methods of use thereof
granted -
US 11484531
Methods for treating chronic obstructive pulmonary disease
granted -
US 11484525
Mu opioid receptor modulators
granted -
US 11485738
Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors
granted -
US 11484545
Compounds and methods for treating neurological and cardiovascular conditions
granted -
US 11485750
STAT degraders and uses thereof
granted -
WO 2022226311
COMPOSITIONS NUTRITIONNELLES COMPRENANT DES OLIGOSACCHARIDES DE LAIT HUMAIN ET UN CONSTITUANT LIPIDIQUE DÉSIGNÉ D'AMÉLIORATION DE FONCTION PULMONAIRE
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.